Search Results - "ROBBERECHT, WIM"

Refine Results
  1. 1

    The changing scene of amyotrophic lateral sclerosis by Robberecht, Wim, Philips, Thomas

    Published in Nature reviews. Neuroscience (01-04-2013)
    “…Key Points Amyotrophic lateral sclerosis (ALS) is a clinical, genetic and pathogenic heterogenous condition. It lies at one end of a spectrum of a single…”
    Get full text
    Journal Article
  2. 2

    The phenotypic variability of amyotrophic lateral sclerosis by Swinnen, Bart, Robberecht, Wim

    Published in Nature reviews. Neurology (01-11-2014)
    “…Key Points Amyotrophic lateral sclerosis (ALS) is a highly heterogeneous entity Cognitive impairment is a common feature of ALS: frontotemporal dementia and…”
    Get full text
    Journal Article
  3. 3

    Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease by Philips, Thomas, MSc, Robberecht, Wim, Prof

    Published in Lancet neurology (01-03-2011)
    “…Summary Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) are characterised by the…”
    Get full text
    Journal Article
  4. 4

    RNA toxicity in non‐coding repeat expansion disorders by Swinnen, Bart, Robberecht, Wim, Van Den Bosch, Ludo

    Published in The EMBO journal (02-01-2020)
    “…Several neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA) are caused by non‐coding nucleotide repeat…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Modelling amyotrophic lateral sclerosis: progress and possibilities by Van Damme, Philip, Robberecht, Wim, Van Den Bosch, Ludo

    Published in Disease models & mechanisms (01-05-2017)
    “…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that primarily affects the motor system and presents with progressive muscle weakness. Most…”
    Get full text
    Journal Article
  7. 7

    Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS by Jovičić, Ana, Mertens, Jerome, Boeynaems, Steven, Bogaert, Elke, Chai, Noori, Yamada, Shizuka B, Paul, Joseph W, Sun, Shuying, Herdy, Joseph R, Bieri, Gregor, Kramer, Nicholas J, Gage, Fred H, Van Den Bosch, Ludo, Robberecht, Wim, Gitler, Aaron D

    Published in Nature neuroscience (01-09-2015)
    “…C9orf72 mutations are the most common cause of amyotrophic lateral sclerosis and frontotemporal dementia. With unbiased screens in Saccharomyces cerevisiae ,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo by Beel, Sander, Moisse, Matthieu, Damme, Markus, De Muynck, Louis, Robberecht, Wim, Van Den Bosch, Ludo, Saftig, Paul, Van Damme, Philip

    Published in Human molecular genetics (01-08-2017)
    “…Loss of function mutations in progranulin (GRN) cause frontotemporal dementia, but how GRN haploinsufficiency causes neuronal dysfunction remains unclear. We…”
    Get full text
    Journal Article
  10. 10
  11. 11

    HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease by d'Ydewalle, Constantin, Krishnan, Jyothsna, Chiheb, Driss M, Van Damme, Philip, Irobi, Joy, Kozikowski, Alan P, Berghe, Pieter Vanden, Timmerman, Vincent, Robberecht, Wim, Van Den Bosch, Ludo

    Published in Nature medicine (01-08-2011)
    “…Charcot-Marie-Tooth type 2 disease is characterized by peripheral axon loss and motor and sensory dysfunction. Constantin d'Ydewalle et al . demonstrate that…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival by Van Damme, Philip, Van Hoecke, Annelies, Lambrechts, Diether, Vanacker, Peter, Bogaert, Elke, van Swieten, John, Carmeliet, Peter, Van Den Bosch, Ludo, Robberecht, Wim

    Published in The Journal of cell biology (07-04-2008)
    “…Recently, mutations in the progranulin (PGRN) gene were found to cause familial and apparently sporadic frontotemporal lobe dementia (FTLD). Moreover, missense…”
    Get full text
    Journal Article
  17. 17

    Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study by Schrooten, Maarten, Smetcoren, Charlotte, Robberecht, Wim, Van Damme, Philip

    Published in Annals of neurology (01-07-2011)
    “…Objective: Early and accurate diagnosis of amyotrophic lateral sclerosis (ALS) is important for patient care and for entry in clinical trials. Retrospective…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis by Nonneman, Annelies, Criem, Nathan, Lewandowski, Sebastian A., Nuyts, Rik, Thal, Dietmar R., Pfrieger, Frank W., Ravits, John, Van Damme, Philip, Zwijsen, An, Van Den Bosch, Ludo, Robberecht, Wim

    Published in Neurobiology of disease (01-11-2018)
    “…Amyotrophic lateral sclerosis (ALS) is a late-onset devastating degenerative disease mainly affecting motor neurons. Motor neuron degeneration is accompanied…”
    Get full text
    Journal Article
  20. 20

    Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice by Beel, Sander, Herdewyn, Sarah, Fazal, Raheem, De Decker, Mathias, Moisse, Matthieu, Robberecht, Wim, Van Den Bosch, Ludo, Van Damme, Philip

    Published in Molecular neurodegeneration (16-10-2018)
    “…TAR DNA binding protein 43 (TDP-43) is the main disease protein in most patients with amyotrophic lateral sclerosis (ALS) and about 50% of patients with…”
    Get full text
    Journal Article